C.-F. Lin et al. / Journal of Organometallic Chemistry 694 (2009) 2757–2769
2767
counting instrument. Samples were degassed via freeze-thaw-
4.3. General procedure for the synthesis of (pyr)2Ir(acac)
pump cycle at least three times prior to measurements. Samples
were excited at 337 nm from a nitrogen pulsed flashlamp with
1 ns FWHM pulse duration transmitted through a Czerny–Turner
design monochromator. Emission was detected at 90° via a second
Czerny–Turner design monochromator onto a thermoelectrically
cooled red-sensitive photomultiplier tube. The resulting photon
counts were stored on a microprocessor-based multichannel ana-
lyzer. The instrument response function was profiled using a scat-
ter solution and subsequently deconvoluted from the emission
data to yield an undisturbed decay. Nonlinear least square fittings
of the decay curves were performed with the Levenburg–Marqu-
ardt algorithm and implemented by the Edinburgh Instruments
F900 software. The reported values represent the average of at
least three readings.
.
To a flask containing IrCl3 nH2O (176 mg, 0.50 mmol) and 1.0
equiv. of pyr ligands, a 3:1 mixture of 2-ethoxyethanol and water
(25 mL) was added. The mixture was then refluxed for 48 h and
cooled to room temperature. After cooling, the reaction was
quenched by water and the resulting mixture was washed with
acetone and hexanes. The solid formed was collected by filtration
and pumped dry to give the crude product of the l-chloro-bridged
Ir(III) dimer. This crude product was mixed with Na2CO3 (0.30 g,
3.0 mmol), 2,4-pentanedione (0.30 g, 3.0 mmol) and 2-methoxy-
ethanol (20 mL) in a flask. The mixture was then heated to reflux
for 24 h. After cooling, the reaction was quenched by water and
the mixture was extracted with CH2Cl2. The combined extracts
were then washed with brine, dried over MgSO4, and evaporated
to dryness. The crude product was purified by column chromatog-
raphy on a silica gel column using a mixture of CH2Cl2 and hexanes
(1:1 by volume) as the eluent.
4.2. General procedure for the syntheses of pyrimidine ligands
Pyrimidine ligands were obtained via sequential palladium-cat-
alysed Suzuki cross-coupling reactions with appropriate arylbornic
acid. A mixture of arylboronic acid (10 mmol), 5-bromo-2-iodopyr-
imidine (2.85 g, 10 mmol), Na2CO3 (10 ml, 2 M in H2O, 20 mmol),
and Pd(PPh3)4 (115 mg, 1.0 mol%) and toluene (25 ml) was refluxed
for 24 h under nitrogen. The resulting mixture was allowed to cool
to room temperature, diluted with CH2Cl2 (10 mL) and extracted
with brine. Combined organic extracts were dried over MgSO4.
The concentrated crude intermediate was purified by column chro-
matography on silica gel and eluted with CH2Cl2/hexanes. The
intermediate then underwent a second Suzuki cross-coupling reac-
tion with another arylboronic acid under similar condition except
that PtBu3 was added as the cocatalyst.
2,5-Bis-(4-tert-butyl-phenyl)-pyrimidine (1): White powders.
Yield = 70%. 1H NMR (400 MHz, CDCl3): d 8.99 (s, 2H, pyrimidine),
8.38 (d, 2H, J = 8.4 Hz, C6H4), 7.53 (m, 6H, C6H4), 1.36 (s, 18H,
CH3). FABMS: m/z 345.2 (M+H)+.
5-(4-tert-Butyl-phenyl)-2-(4-trifluoromethyl-phenyl)-pyrimidine
(2): White powders. Yield = 70%. 1H NMR (400 MHz, CDCl3): d 9.02
(s, 2H, pyrimidine), 8.60 (d, 2H, J = 7.6 Hz, C6H4CF3), 7.75 (d, 2H,
J = 7.6 Hz, C6H4CF3), 7.57 (m, 4H, C6H4), 1.37 (s, 9H, CH3). FABMS:
m/z 357.2 (M+H)+.
Compound 8: Orange powders. Yield = 12%. 1H NMR (400 MHz,
CDCl3):
d 8.95 (d, 2H, J = 2.8 Hz, pyrimidine), 8.89 (d, 2H,
J = 2.8 Hz, pyrimidine), 7.84 (d, 2H, J = 8.4 Hz, C6H3), 7.56 (s, 8H,
C6H4), 6.93 (d, 2H, J = 8.4 Hz, C6H3), 6.33 (s, 2H, C6H3), 5.19 (s, 1H,
acac-CH), 1.79 (s, 6H, acac-CH3), 1.37 (s, 18H, CH3), 1.05 (s, 18H,
CH3). FABMS: m/z 978.4 (M+). Anal. Calc. for C53H61N4O2Ir: C,
65.07; H, 6.28; N, 5.73. Found: C, 64.86; H, 6.08; N, 5.71%.
Compound 9: Yellow–orange powders. Yield = 21%. 1H NMR
(400 MHz, CDCl3): d 9.06 (s, 2H, pyrimidine), 8.86 (s, 2H, pyrimi-
dine), 8.07 (d, 2H, J = 8.4 Hz, C6H3CF3), 7.58 (d, 8H, J = 1.2 Hz,
C6H4CF3), 7.14 (d, 2H, J = 8.4 Hz, C6H3CF3), 6.52 (s, 2H, C6H3CF3),
5.28 (s, 1H, acac-CH), 1.82 (s, 6H, acac-CH3), 1.37 (s, 18H, CH3).
FABMS: m/z 1002.0 (M+). Anal. Calc. for C47H43F6N4O2Ir: C, 56.33;
H, 4.33; N, 5.59. Found: C, 56.07; H, 4.21; N, 5.38%.
Compound 10: Yellow powders. Yield = 12%. 1H NMR (400 MHz,
CDCl3): d 8.99 (d, 2H, J = 2.8 Hz, pyrimidine), 8.79 (d, 2H, J = 2.8 Hz,
pyrimidine), 7.98 (td, 2H, J = 8.8 and 2.4 Hz, C6H3F), 7.57 (s, 8H,
C6H4), 6.62 (td, 2H, J = 8.8 and 2.4 Hz, C6H3F), 5.98 (d, 1H,
J = 2.4 Hz, C6H3F), 5.96 (d, 1H, J = 2.4 Hz, C6H3F), 5.30 (s, 1H, acac-
CH), 1.82 (s, 6H, acac-CH3), 1.37 (s, 18H, CH3). FABMS: m/z 902.2
(M+). Anal. Calc. for: C45H43F2N4O2Ir: C, 59.92; H, 4.80; N, 6.21.
Found: C, 60.09; H, 4.60; N, 6.00%.
5-(4-tert-Butyl-phenyl)-2-(4-fluoro-phenyl)-pyrimidine
(3):
Compound 11: Yellow powders. Yield = 31%. H NMR (400 MHz,
CDCl3): d 8.92 (d, 2H, J = 2.8 Hz, pyrimidine), 8.80 (d, 2H,
White powders. Yield = 92%. 1H NMR (400 MHz, CDCl3): d 8.98 (s,
2H, pyrimidine), 8.46–8.44 (m, 2H, C6H4F), 7.57–7.52 (m, 4H,
C6H4), 7.5 (td, 2H, J = 8.8 and 2.4 Hz, C6H4F), 1.35 (s, 9H, CH3). FAB-
MS: m/z 306.1 (M+).
J = 2.8 Hz, pyrimidine), 7.91 (d, 2H, J = 8.4 Hz, C6H3), 7.55 (s, 8H,
C6H4), 6.49 (d, 2H, J = 8.4 Hz, C6H3), 5.87 (s, 2H, C6H3), 5.22 (s, 1H,
acac-CH), 3.57 (s, 6H, OCH3), 1.81 (s, 6H, acac-CH3), 1.37 (s, 18H,
CH3). FABMS: m/z 926.2 (M+). Anal. Calc. for: C47H49N4O4Ir: C,
60.95; H, 5.33; N, 6.05. Found: C, 60.70; H, 4.97; N, 5.75%.
Compound 12: Yellow powders. Yield = 12%. 1H NMR (400 MHz,
CDCL3): d 9.06 (d, 2H, J = 2.8 Hz, pyrimidine), 8.86 (s, 2H, J = 2.8 Hz,
pyrimidine), 8.23 (s, 2H, C6H3CF3), 7.58 (s, 8H, C6H4), 6.99 (d, 2H,
J = 8.0 Hz, C6H3CF3), 6.47 (d, 2H, J = 8.0 Hz, C6H3CF3), 5.28 (s, 1 H,
acac-CH), 1.82 (s, 6H, acac-CH3), 1.37 (s, 18H, CH3). FABMS: m/z
1002.5 (M+). Anal. Calc. for: C47H43F2F6N4O2Ir: C, 56.33; H, 4.33;
N, 5.59. Found: C, 56.73; H, 4.49; N, 5.43%.
5-(4-tert-Butyl-phenyl)-2-(4-methoxy-phenyl)-pyrimidine
(4):
White powders. Yield = 76%. 1H NMR (400 MHz, CDCl3): d 8.98 (s,
2H, pyrimidine), 8.41 (dd, 2H, J = 8.8 and 2.0 Hz, C6H4OMe), 7.56–
7.51 (m, 4H, C6H4), 7.00 (dd, 2H, J = 8.8 and 2.0 Hz, C6H4OCH3),
3.88 (s, 3H, OCH3), 1.36 (s, 9H, CH3). FABMS: m/z 319.2 (M+H)+.
5-(4-tert-Butyl-phenyl)-2-(3-trifluoromethyl-phenyl)-pyrimidine (5):
White powders. Yield = 73%. 1H NMR (400 MHz, CDCl3): d 9.02 (s,
2H, pyrimidine), 8.82 (s, 1H, C6H4CF3), 8.66 (d, 1H, J = 7.6 Hz,
C6H4CF3), 7.73 (d, 1H, J = 7.6 Hz, C6H4CF3), 7.58 (m, 5H, C6H4 and
C6H4CF3), 1.37 (s, 9H, CH3). FABMS: m/z 357.1 (M+H)+.
Compound 13: Yellow powders. Yield = 26%. 1H NMR (400 MHz,
CDCl3): d 9.09 (d, 2H, J = 2.8 Hz, pyrimidine), 8.86 (d, 2H, J = 2.8 Hz,
pyrimidine), 8.27 (s, 2H, C6H3CF3), 7.86–7.73 (m, 8H, C6H4CF3), 7.03
(d, 2H, J = 8.0 Hz, C6H3CF3), 6.47 (d, 2H, J = 8.0 Hz, C6H3CF3), 5.32 (s,
1 H, acac-CH), 1.84 (s, 6H, acac-CH3). FABMS: m/z 1026.2 (M+).
Anal. Calc. for C41H25F12N4O2Ir: C, 48.00; H, 2.46; N, 5.46. Found:
C, 48.12; H, 2.41; N, 5.42%.
2-(3-Trifluoromethyl-phenyl)-5-(4-trifluoromethyl-phenyl)-pyrim-
idine (6): White powders. Yield = 67%. 1H NMR (400 MHz, CDCl3): d
9.04 (s, 2H, pyrimidine), 8.79 (s, 1H, C6H4CF3), 8.69 (d, 1H,
J = 7.6 Hz, C6H4CF3), 7.76 (m, 5H, C6H4CF3 and C6H4), 7.63 (t, 1H,
J = 8.0 Hz, C6H4CF3). FABMS: m/z 369.1 (M+H)+.
5-Thiophen-2-yl-2-(3-trifluoromethyl-phenyl)-pyrimidine
(7):
White powders. Yield = 65%.1H NMR (400 MHz, CDCl3): d 9.02 (s,
2 H, pyrimidine), 8.75 (s, 1H, C6H4CF3), 8.65 (d, 1H, J = 7.6 Hz,
C6H4CF3), 7.73 (d, 1H, J = 7.6 Hz, C6H4CF3), 7.61 (t, 1H, J = 7.6 Hz,
C6H4CF3), 7.45–7.44 (m, 2H, thiophene), 7.17 (t, 1H, J = 4.0 Hz, thi-
ophene). FABMS: m/z 307.2 (M+H)+.
Compound 14: Orange powders. Yield = 22%. 1H NMR (400 MHz,
CDCl3): d 9.05 (d, 2H, J = 2.8 Hz, pyrimidine), 8.83 (d, 2H, J = 2.8 Hz,
pyrimidine), 8.21 (s, 2H, C6H3CF3), 7.47 (m, 4H, thiophene), 7.19 (t,
2H, J = 3.6 Hz, thiophene), 7.00 (d, 2H, J = 8.0 Hz, C6H3CF3), 6.47 (d,
2H, J = 8.0 Hz, C6H3CF3), 5.31 (s, 1H, acac-CH), 1.87 (s, 6H, acac-